EGFR and cancer: Interestingly, compared with wild-type PKM2, expression of R399E mutant PKM2 could more greatly enhance EGFR phosphorylation, cellular transformation and cell proliferation [37], which unveils a new effect of extracellular PKM2 on promoting cancer cell proliferation through EGFR activation (Figure 2C).